Price List - Foundayo - Metabolic Dysfunction A - Weight Loss A.xlsx

XLSX spreadsheet 47 KB Posted

Attached to
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation number
HT9402-26-Q-9203
Issued by

About this file

This is a price list template for the Department of War (DoW) Pharmacy and Therapeutics (P&T) Committee's May 6-7, 2026 meeting for newly approved weight loss agents within the Metabolic Dysfunction therapeutic class. The document is a Blanket Purchase Agreement (BPA) and Uniform Formulary Additional Discount Program (ADP) pricing template for the Foundayo drug product. The price list contains multiple appendices structured for ten newly approved drugs, each with separate sections for BPA pricing (Military Treatment Facility and Mail Order scenarios) and ADP pricing options (non-FAMP discount and WAC discount methodologies for TRICARE retail refunds). Manufacturers must submit quotes by April 27, 2026, and are required to submit a Quote Review Checklist and fully executed signature pages along with quote information.

The pricing structure requires manufacturers to provide price per NDC package size and price per unit for both Uniform Formulary and Non-Formulary scenarios within the BPA section. For the ADP sections, manufacturers must provide either non-FAMP pricing with additional offered refund percentages or WAC pricing with discount percentages for Tier 2 and Tier 3 formulary categories. All pricing is subject to step therapy requirements with no grandfathering, meaning prior authorization will require patients to complete adequate trials of step-preferred agents before non-step-preferred agents can be dispensed. The document notes that pricing per unit must remain consistent across all available package sizes within a given dispensing venue, and that agents not receiving quotes or selected may be designated as non-step preferred (after-step) agents.

View the file

Other files

Show all 12

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

BPA

UF BPA NDC Price List for the May 2026 DoW P&T Meeting
DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
Formulary Notes
Class Note(s): Prior Authorization (PA) may apply. Agents may be identified as possible candidates for special reimbursement methods, amounts, and procedures to encourage use of high-value products and discourage use of low-value products. The DoD P&T Committee may recommend consideration of preferential status to any non-generic pharmaceutical agent by treating it for purposes of cost sharing as a generic product (Tier 1). Similarly, the DoD P&T Committee may identify candidates to recommend for complete exclusion from the TRICARE pharmacy benefit program.

Step Therapy Addendum: No grandfathering: a prior authorization process requires all new and current patients to complete an adequate trial of the step-preferred agent(s) before a non-step-preferred agent is provided to the patient at any MTF, Retail, or Mail point of service.

Agents with RFQ not submitted or selected may be designated non-step preferred (after-step).

Notes to Manufacturers: Do not forget to submit the Quote Review Checklist and fully executed signature pages, along with quote information.

The price per unit of measure for a given dosage form and strength (each, gram, mL, etc.) of the pharmaceutical agent will be the same for all available package sizes (e.g., 30s, 100s, 1000s) within a given dispensing venue.

Blanket Purchase Agreement Appendix – Newly Approved Drug

#1DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#2DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#3DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#4DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#5DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#6DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#7DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#8DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#9DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#10DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1261MDWLG0UF1MUniform Formulary1 or moreNO QUOTE
261MDWLG0NF1MNon-Formulary1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

ADP (non-FAMP Discount)

UF ADP Appendix for the May 2026 DoW P&T Meeting
DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
Formulary Notes
Class Note(s): Prior Authorization (PA) may apply. Agents may be identified as possible candidates for special reimbursement methods, amounts, and procedures to encourage use of high-value products and discourage use of low-value products. The DoD P&T Committee may recommend consideration of preferential status to any non-generic pharmaceutical agent by treating it for purposes of cost sharing as a generic product (Tier 1). Similarly, the DoD P&T Committee may identify candidates to recommend for complete exclusion from the TRICARE pharmacy benefit program.

Step Therapy Addendum: No grandfathering: a prior authorization process requires all new and current patients to complete an adequate trial of the step-preferred agent(s) before a non-step-preferred agent is provided to the patient at any MTF, Retail, or Mail point of service.

Notes to Manufacturers: Do not forget to submit the Quote Review Checklist and fully executed signature pages, along with quote information.

* Total Calculated Refund Per FCP is calculated as: ((non-FAMP-FCP)+(non-FAMP*Y%)) = Total Calculated Refund **Based on the most recent annual non-FAMP (reported to the Department of Veterans Affairs) from which the current annual Federal Ceiling Price (FCP) calculated ceiling is derived. The current annual FCP and the annual non-FAMP from which it is derived will be applicable to all prescriptions filled during a calendar year. The quoted additional refund percentage will remain static during the life of the agreement but the most recent annual non-FAMP, and thus the calculated refund, may change each calendar year.

Additional Discount Program Appendix – Newly Approved Drug

#1DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#2DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#3DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#4DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote
Additional Discount Program Appendix – Newly Approved Drug
#5DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#6DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#7DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#8DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#9DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote
Additional Discount Program Appendix – Newly Approved Drug
#10DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

ADP (WAC Discount)

UF ADP Appendix for the May 2026 DoW P&T Meeting
DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
Formulary Notes
Class Note(s): Prior Authorization (PA) may apply. Agents may be identified as possible candidates for special reimbursement methods, amounts, and procedures to encourage use of high-value products and discourage use of low-value products. The DoD P&T Committee may recommend consideration of preferential status to any non-generic pharmaceutical agent by treating it for purposes of cost sharing as a generic product (Tier 1). Similarly, the DoD P&T Committee may identify candidates to recommend for complete exclusion from the TRICARE pharmacy benefit program.

Step Therapy Addendum: No grandfathering: a prior authorization process requires all new and current patients to complete an adequate trial of the step-preferred agent(s) before a non-step-preferred agent is provided to the patient at any MTF, Retail, or Mail point of service.

Notes to Manufacturers: Do not forget to submit the Quote Review Checklist and fully executed signature pages, along with quote information.

The Wholesale Acquisition Cost (WAC) is obtained from First Databank via daily price updates; it is maintained at the dispensing unit level to five (5) decimal places. If the WAC changes during a calendar quarter, an average WAC will be calculated on a daily weighted basis (per unit only).

WAC is ONLY used for products that do not have a FCP, such as diabetic supplies (i.e., test strips), and can also be applied to covered drugs.

*The quoted WAC Discount percentage will remain static during the life of the agreement.

Additional Discount Program Appendix – Newly Approved Drug

#1DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#2DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#3DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#4DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#5DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#6DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#7DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#8DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#9DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#10DoW Uniform Formulary Class:METABOLIC DYSFUNCTION AGENTSP&T Committee Meeting:May 6-7, 2026
DoW Uniform Formulary Subclass:WEIGHT LOSS AGENTSQuotes due:April 27, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1261MDWLG0T21MTier 21 or more
261MDWLG0T31MTier 31 or more
If cell highlights red, please confirm intent not to submit a quote

File details come from the government source that posted it. Updated .